ARTICLE | Clinical News
DHEA data
January 15, 1996 8:00 AM UTC
Positive results of a double-blind, placebo-controlled, randomized Phase II trial in 28 women with mild to moderate SLE were published in Arthritis and Rheumatism.
Patients on placebo neither improved nor reduced doses of the steroid (p=0.022). Lupus flares occurred more frequently in the placebo group (p=0.053). ...